PAS MP Dan Perciun said that he received multiple complaints from patients who suffer from diabetes mellitus, who related that owing to the schemes and interests in the field, their health is in danger. More exactly, the diabetics are put in the situation to administer expired insulin, to use another type of insulin than the ordinary one or to look for the insulin they need themselves, outside the health system, IPN reports.
“In the Republic of Moldova, there are 120,000 persons who suffer from diabetes mellitus and 18,000 of them are treated with insulin. The quality of their life is directly affected by the interests that prevail in this system which, instead of placing emphasis on patients’ interests, aims to enrich decision makers that are connected to the provision of insulin and medical devices for diabetics. The people suffer, their health is in danger owing to the poor management of public procurement at all the stages,” Dan Perciun stated in a news conference.
According to him, the people said they were told that insulin NovoRapid will no longer be supplied and the doctor will issue a prescription for a new type of insulin to them. The patients have to use expired insulin because of the schemes and interests and, owing to the lack of capacity to estimate the real necessities of insulin, more insulin than needed is supplied. This leads to the waste of public funds.
“We ask the Ministry of Health to intervene urgently and to ensure the proper management of the supplies so as to exclude the situations when the patients are issued with insulin whose period of validity expires when this is to be administered. To definitively solve this problem, the PAS commits itself to be making effort to ensure the switch over to the system for supplying the diabetics with insulin and medical devices by compensation, after the snap parliamentary elections,” said Dan Perciun, noting that the diabetics this way will be able to go to drugstores after insulin or the medical device they need and the state will later pay for these.